March 20, 2024

Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer

JYJames B. YuDartmouth College DDDavid DeStephanoColumbia University Irving Medical Center BJBrian JeffersColumbia University Irving Medical Center

Key Points

Key points are not available for this paper at this time.

Abstract

Previous comparative effectiveness studies have not demonstrated a benefit of proton beam therapy (PBT) compared with intensity-modulated radiation therapy (IMRT) for prostate cancer. An updated comparison of GI and genitourinary (GU) toxicity is needed.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Yu et al. (Wed,) studied this question.

synapsesocial.com/papers/68e732b8b6db6435876abc62 https://doi.org/https://doi.org/10.1200/jco.23.01604

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy2019 · 90 citations
2A review of proton therapy – Current status and future directions2022 · 229 citations
3Bias Reduction Using Mahalanobis-Metric Matching1980 · 531 citations
4A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients2021 · 28 citations
5Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques2022 · 5 citations

Demander à l'IA

Bookmark

View Full Paper